Home |  News

Promentis Pharmaceuticals Commences Phase 1 Study for SXC-2023 Targeting Neuropsychiatric Disorders

Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, today announced that it has commenced a Phase 1 single ascending dose study for its lead compound, SXC-2023. Promentis is developing SXC-2023 and other compounds that engage System xc-, a central nervous system (CNS) target addressing glutamatergic imbalance and oxidative stress, to treat obsessive-compulsive and related disorders, substance-related and addictive disorders and other neuropsychiatric disorders. SXC-2023 has demonstrated a compelling profile across a range of non-clinical studies.

Three winners awarded $20,000 at Healthcare Innovation Pitch competition

Three teams of entrepreneurs claimed a total of $60,000 in seed funding for their winning health care innovations at the Healthcare Innovation Pitch event held Wednesday as part of Milwaukee Startup Week. The winners were among 11 teams to pitch their health care innovations to a panel of venture capitalists in the Shark Tank-style event put on by Wauwatosa-based Bridge to Cures. Milwaukee Commissioner of Health Bevan Baker spoke at the Healthcare Innovation Pitch event at the Hilton Milwaukee City Center.

New Partnership with Shorewood School District to Spur “Authentic Learning”

The University of Wisconsin-Milwaukee’s (UWM) Lubar Entrepreneurship Center and the Shorewood School District have announced a new Teaching Fellows partnership to cultivate Authentic Learning in grades 7-12.  The new Fellows program, supported by a grant from the Shorewood SEED Foundation, will tap into UWM’s expertise and provide professional development for Shorewood teachers as they build new and innovative educational opportunities for students.

Engineering, nursing ‘hackathon’ explores solutions to health care issues

A National Science Foundation grant is helping UWM’s College of Engineering & Applied Science work with other disciplines on campus to bring more women and underrepresented groups into innovation. In January, UWM became one of eight National Science Foundation I-Corps sites to receive $30,000 to promote inclusion of underrepresented populations in the National Innovation Network.

Establishing the Lubar Entrepreneurship Center at UWM

On this week’s program, a discussion of the critical need for innovation and entrepreneurship in Milwaukee and the region. WUWM’s Dave Edwards talks with UW-Milwaukee Chancellor Mark Mone; Julia Taylor, president of the Greater Milwaukee Committee; and Sheldon Lubar. Mr. Lubar and his family donated $10 million to UWM to establish the Lubar Entrepreneurship Center.

How High-Tech Entrepreneurs Are Energizing Milwaukee

If you sense that something is stirring or hear a buzz, it might just be the sound of Milwaukee’s high-tech community building the foundation for a new entrepreneurial economy. In the past several years, an outcropping of high-tech entrepreneurs has emerged here, universities have gone all out to teach entrepreneurial skills, and established companies are on board to support this emerging startup ecosystem. But perceptions change slowly, as the underlying reality shifts.

UWM-developed app helps protect patients’ brains during surgery

The work of some UWM students is literally helping make people’s lives better. The students in UWM’s App Brewery worked with doctors at the Medical College of Wisconsin to develop an app that helps guide doctors during the delicate process of brain surgery. Incredibly, patients are awake during the surgery. The app, called NeuroMapper, is a tablet-based tool that aids surgeons who are removing a tumor or tissue by helping them test whether they are encroaching on tissue that would impair functions if removed.